These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Lymphocytic and lymphocytoactive components in the etiopathogenic mechanisms of systemic lupus erythematosus. An analysis of the literature]. Angela GC; Cavallo G; Fiorio C G Batteriol Virol Immunol; 1983; 76(1-6):25-42. PubMed ID: 6237017 [TBL] [Abstract][Full Text] [Related]
23. Anti-DNA antibody in procainamide-induced lupus erythematosus. Determinations using DNA fractionated by methylated albumin-Kieselguhr chromatography. Winfield JB; Davis JS Arthritis Rheum; 1974; 17(2):97-110. PubMed ID: 4544445 [No Abstract] [Full Text] [Related]
24. Procainamide-induced lupus syndrome in siblings. Novack MA; Paine R JAMA; 1975 Jun; 232(12):1269. PubMed ID: 48561 [No Abstract] [Full Text] [Related]
26. Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupus. Adams LE; Sanders CE; Budinsky RA; Donovan-Brand R; Roberts SM; Hess EV J Lab Clin Med; 1989 Apr; 113(4):482-92. PubMed ID: 2539420 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Con A mitogenesis by serum from procainamide-treated patients and patients with systemic lupus erythematosus. Tannen RH; Cunningham-Rundles S Immunol Commun; 1982; 11(1):33-45. PubMed ID: 6178682 [TBL] [Abstract][Full Text] [Related]
35. Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy. Anastassiades TP; Miliiken JA Can Med Assoc J; 1972 Aug; 107(4):312-5. PubMed ID: 4538330 [No Abstract] [Full Text] [Related]
37. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus. Rubin RL; Burlingame RW; Arnott JE; Totoritis MC; McNally EM; Johnson AD J Immunol; 1995 Mar; 154(5):2483-93. PubMed ID: 7868914 [TBL] [Abstract][Full Text] [Related]